Loading
A phase 2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), tegafur, gimeracil and oteracil (S-1), leucovorin (folinic acid) and other drugs in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting.
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer is a phase 2, randomised interventional study registered as NCT06383078 by The First Affiliated Hospital with Nanjing Medical University, with a registry enrolment figure of 120 participants, started 2024-04-20 and due to reach its primary completion in 2027-03-01. Interventions recorded: HR070803; Oxaliplatin; Tegafur; Folinic acid; 5-Fluorouracil. Conditions listed: Efficacy and Safety. Primary outcome: 1-year Disease-free survival rate. Pancreatic eligibility wording from the registry: "Histologically confirmed resected ductal pancreatic adenocarcinoma with macroscopic complete resection (R0 and R1)". No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Tegafur, gimeracil and oteracil (S-1), Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/